Vericel Corp. (VCEL)
54.62
+2.84
(+5.48%)
USD |
NASDAQ |
Nov 06, 16:00
55.10
+0.48
(+0.88%)
After-Hours: 20:00
Vericel EPS Diluted (TTM) : 0.4623 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4623 |
| March 31, 2026 | 0.4091 |
| December 31, 2025 | 0.3078 |
| September 30, 2025 | 0.2408 |
| June 30, 2025 | 0.1246 |
| March 31, 2025 | 0.0394 |
| December 31, 2024 | 0.1846 |
| September 30, 2024 | 0.0624 |
| June 30, 2024 | 0.004 |
| March 31, 2024 | -0.0053 |
| December 31, 2023 | -0.0833 |
| September 30, 2023 | -0.2201 |
| June 30, 2023 | -0.2827 |
| March 31, 2023 | -0.3674 |
| December 31, 2022 | -0.3601 |
| September 30, 2022 | -0.3897 |
| June 30, 2022 | -0.356 |
| March 31, 2022 | -0.2474 |
| December 31, 2021 | -0.168 |
| September 30, 2021 | -0.0048 |
| June 30, 2021 | 0.1774 |
| March 31, 2021 | 0.0758 |
| December 31, 2020 | 0.0426 |
| September 30, 2020 | -0.0084 |
| June 30, 2020 | -0.0105 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2776 |
| December 31, 2019 | -0.2379 |
| September 30, 2019 | -0.3273 |
| June 30, 2019 | -0.4266 |
| March 31, 2019 | -0.0963 |
| December 31, 2018 | -0.2432 |
| September 30, 2018 | -0.3468 |
| June 30, 2018 | -0.4819 |
| March 31, 2018 | -0.4319 |
| December 31, 2017 | -0.53 |
| September 30, 2017 | -0.88 |
| June 30, 2017 | -1.10 |
| March 31, 2017 | -1.25 |
| December 31, 2016 | -1.18 |
| September 30, 2016 | -1.12 |
| June 30, 2016 | -1.00 |
| March 31, 2016 | -0.94 |
| December 31, 2015 | -0.97 |
| September 30, 2015 | -0.86 |
| June 30, 2015 | -1.42 |
| March 31, 2015 | -2.20 |
| December 31, 2014 | -3.19 |
| September 30, 2014 | -9.64 |
| June 30, 2014 | -10.02 |
| March 31, 2014 | -11.28 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.105 |
| Alnylam Pharmaceuticals, Inc. | 19.80 |
| Anika Therapeutics, Inc. | -0.1126 |
| Savara, Inc. | -0.5766 |
| Biogen, Inc. | 2.336 |